
Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 893 | 893 | 1074 | - | - | - |
Fund Return | -10.71% | -10.71% | 7.44% | - | - | - |
Place in category | 95 | 95 | 88 | - | - | - |
% in Category | 97 | 97 | 100 | - | - | - |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
INF966L01689 | 228.32B | -11.46 | 21.86 | 19.42 | ||
INF966L01051 | 228.32B | -11.66 | 20.48 | 18.57 | ||
Quant Mid Cap Fund Growth | 76.16B | -7.88 | 17.03 | 16.14 | ||
INF966L01887 | 76.16B | -7.61 | 18.84 | 17.39 | ||
Quant Consumption Fund Growth | 61.89B | -4.91 | 16.05 | 18.05 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Reliance Pharma Fund - Bonus | 76.37B | -8.69 | 18.38 | 13.34 | ||
Reliance Pharma Dividend Payout | 76.37B | -9.44 | 17.76 | 14.28 | ||
Reliance Pharma Fund - Growth | 76.37B | -8.69 | 18.38 | 13.34 | ||
Reliance Pharma Direct Bonus | 76.37B | -8.49 | 19.44 | 14.35 | ||
Reliance Pharma Direct Growth | 76.37B | -8.49 | 19.44 | 14.35 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Divi's Labs | INE361B01024 | 9.67 | 5,589.30 | +3.77% | |
RPG Life Sciences Limited | INE105J01010 | 9.05 | 2,063.95 | +4.80% | |
Aster DM Healthcare | INE914M01019 | 8.18 | 500.30 | +1.53% | |
Zydus Lifesciences | INE010B01027 | 7.39 | 868.85 | +2.90% | |
Ipca Laboratories | INE571A01038 | 7.13 | 1,330.95 | +2.79% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Sell | Sell | Neutral |
Technical Indicators | Strong Sell | Strong Sell | Strong Sell |
Summary | Strong Sell | Strong Sell | Sell |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review